Submission date
23/01/2004
Registration date
23/01/2004
Last edited
08/11/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr Christopher Brightling

ORCID ID

Contact details

Glenfield Hospital
Groby Road
Leicester
LE3 9QP
United Kingdom

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

RBF 00XX2

Study information

Scientific title

The value of measuring airway inflammation in the management of asthma

Acronym

Study hypothesis

Test the hypothesis that managing patients with asthma by effectively suppressing airway inflammation, using a standardised protocol, will improve the control of mild exacerbations, airway responsiveness and symptoms compared with standard clinical approach.

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Treatment

Patient information sheet

Condition

Asthma

Intervention

1. Treatment of airways inflammation
2. Standard care

Intervention type

Other

Primary outcome measure

Improved asthma control; control of airway inflammation; change in spirometry over one-year, severe exacerbations; total use of inhaled corticosteroids in each group; proportion of patients screened with a diagnosis of asthma without objective evidence.

Secondary outcome measures

Not provided at time of registration

Overall study start date

19/06/2000

Overall study end date

18/05/2002

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

80 patients with asthma

Participant type(s)

Patient

Age group

Adult

Sex

Both

Target number of participants

80

Total final enrolment

74

Participant exclusion criteria

Does not meet inclusion criteria

Recruitment start date

19/06/2000

Recruitment end date

18/05/2002

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

Glenfield Hospital
Leicester
LE3 9QP
United Kingdom

Sponsor information

Organisation

NHS R&D Regional Programme Register - Department of Health (UK)

Sponsor details

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
+44 (0)20 7307 2622
dhmail@doh.gsi.org.uk

Sponsor type

Government

Website

http://www.doh.gov.uk

Funders

Funder type

Government

Funder name

NHS Executive Trent (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

Not provided at time of registration

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 30/11/2002 Yes No

Additional files

Editorial Notes

08/11/2022: The following changes have been made: 1. Publication reference reclassified as results. 2. The final enrolment number has been added from the reference.